AJTMH ASTMH MEMBERSHIP INFORMATION: astmh@astmh.org
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 53(5), 1995, pp. 571-574
Copyright © 1995 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gonzalez, A. E.
Right arrow Articles by Tsang, V. C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gonzalez, A. E.
Right arrow Articles by Tsang, V. C. W.

Treatment of Porcine Cysticercosis with Albendazole

Armando E. Gonzalez, Hector H. Garcia, Robert H. Gilman, Maria T. Lopez, Cesar Gavidia, Jeff McDonald, Joy B. Pilcher AND Victor C. W. Tsang
Facultad de Medicina Veterinaria, Universidad Nacional Mayor de San Marcos, Lima, Peru; Laboratorio de Parasitologia, Universidad Peruana Cayetano Heredia, Lima, Peru; Department of International Health, Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland; Department of Medicine, University of Utah, Salt Lake City, Utah; Division of Parasitic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia

In a randomized, controlled study, the efficacy and safety of two different schemes of albendazole therapy for treatment of porcine cysticercosis were tested. Seventeen naturally infected pigs were divided into three groups and treated per os with albendazole (50 mg/kg single dose), albendazole (30 mg/kg every day for three days), or given no treatment, respectively. Serologic responses were monitored with the enzyme-linked electroimmunotransfer blot assay. Pigs were humanely killed 12 weeks after treatment, necropsied, and the number of parasites was recorded. Scolex evagination was used to assess viability of the cysts. Both albendazole-treated groups had significant side effects (anorexia, lethargy). Only a single viable cyst was recovered from the brain of one animal after therapy in the multiple-dose group, and the single-dose therapy left 11% of the cysts viable. In contrast, more than 90% of muscle cysts were found to be viable in the untreated group. Although albendazole therapy for three days was found to be highly effective, side effects and the need for multiple doses would still prevent its widespread use.




This article has been cited by other articles:


Home page
 NEJMHome page
I. Rojas-Flores, S. Kumar, H. H. Garcia, R. H. Gilman, and A. E. Gonzalez
A Trial of Antiparasitic Treatment for Cerebral Cysticercosis
N. Engl. J. Med., April 15, 2004; 350(16): 1686 - 1687.
[Full Text] [PDF]

Home page
 NEJMHome page
H. H. Garcia, E. J. Pretell, R. H. Gilman, S. M. Martinez, L. H. Moulton, O. H. Del Brutto, G. Herrera, C. A.W. Evans, A. E. Gonzalez, and the Cysticercosis Working Group in Peru
A Trial of Antiparasitic Treatment to Reduce the Rate of Seizures Due to Cerebral Cysticercosis
N. Engl. J. Med., January 15, 2004; 350(3): 249 - 258.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Society of Tropical Medicine and Hygiene.